bmj;390/sep17_1/r1946/FAF1faDavid Isaacs was considered the father of paediatric infectious diseases in Australia and New Zealand12 but he is […]
Doctors refusing to use “untried and untested” artificial intelligence (AI) software at work will be supported by the […]
The arrival of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide and tirzepatide marks an important moment […]
Contradictory statements suggesting the US incinerated $9.7m (£7.4m; €8.4m) worth of contraceptives intended mostly for low income countries […]
Updated Date: Tue, 09 Sep 2025 00:00:00 EDT
Updated Date: Tue, 09 Sep 2025 00:00:00 EDT
Data from trials highlight long-term disease control and quality of life improvements
First patient dosed in study of novel EP4 antagonist for advanced solid tumours
Updated Date: Tue, 09 Sep 2025 00:00:00 EDT
People taking semaglutide report far fewer obsessive thoughts about food, with cravings dropping sharply and mental health improving. […]